Feed / Theme
Confirmed

Semiconductor Solutions

40 names are moving together; 53% are participating in the current session.

Co-movement

Observed intraday paths are not available for this group yet.

Members

TICKERCompanySectorTodayObserved activity
XENEXenon Pharmaceuticals Inc.Healthcare-2.9%Group member
SLNHSoluna Holdings, Inc.Financial Services-3.1%Group member
CYDChina Yuchai International LimiConsumer Cyclical-1.6%Group member
FJIKYFujikura Ltd.Industrials+2.4%Group member
SITMSiTime CorporationTechnology-3.0%Group member
WDCWestern Digital CorporationTechnology+0.8%Group member
SWKSSkyworks Solutions, Inc.Technology+0.7%Group member
GENBGenerate Biomedicines, Inc.Healthcare-8.8%Group member
SNDKSandisk CorporationTechnology+3.2%Group member
YYGHYY Group Holding LimitedIndustrials+4.8%Group member
VICRVicor CorporationTechnology-1.1%Group member
COHRCoherent Corp.Technology-0.9%Group member
CRNXCrinetics Pharmaceuticals, Inc.Healthcare+0.0%Group member
EHCEncompass Health CorporationHealthcare-0.8%Group member
GFSGlobalFoundries Inc.Technology-1.1%Group member
KLRAKailera Therapeutics, Inc.Healthcare-1.7%Group member
MUMicron Technology, Inc.Technology-1.2%Group member
SYNASynaptics IncorporatedTechnology-2.0%Group member
TMDXTransMedics Group, Inc.Healthcare-1.5%Group member
AIPArteris, Inc.Technology-3.7%Group member
BELFBBel Fuse Inc.Technology+1.0%Group member
NVTSNavitas Semiconductor CorporatiTechnology-5.1%Group member
SEDGSolarEdge Technologies, Inc.Technology+0.8%Group member
ESIElement Solutions Inc.Basic Materials-1.8%Group member

Why we believe this

Cohort

40 names

Participation

53% this session

Observed history

1 daily builds

Filing coverage

35/40 members

demand / volume affecting revenue

This can occur due to many factors, such as reduced demand for our price risk management products and decreased sales to our customers involved in the oil exploration sector.

WKC 10-K

restructuring affecting expense

Management continued to execute these plans in 2026, and as a result of the actions taken during the first quarter of 2026, we recognized charges for exit activities totaling $1.0 million, comprised of charges associated with various legal matters and contract termination costs of $7.8 million and severance and compensation costs of $0.9 million, which were partially offset by a net noncash gain on the sale of assets of $7.7 million.

WKC 10-Q

product pipeline / R&D affecting expense

The unfavorable change of $52.7 million from changes in operating assets and liabilities was primarily attributable to (i) a $21.9 million unfavorable change in accounts payables and accrued other liabilities primarily due to the timing of payments, (ii) a $20.7 million increase in the changes of the prepaid expenses and other assets primarily due to prepayment for a research and development vendor and a higher income tax receivable from excess tax benefits related to equity compensation, and (iii) a $13.9 million unfavorable change in accounts receivable due to higher product sales and the timing of customer payments.

ALAB 10-K

Cross-asset confirmation is still fragile, so spillover can stall before it becomes durable.

Connected, outside the group

No high-confidence filing-linked non-members are available for this group yet.

History

Historical cohort observations are not available yet.